ACCORD BIOPHARMA, INC.

ACCORD BIOPHARMA, INC. specializes in the manufacturing of pharmaceutical preparations, with a demonstrated focus on producing drugs, pharmaceuticals, and hematology-related products for federal healthcare systems. The company operates within the highly regulated biopharmaceutical manufacturing space, ensuring compliance with cGMP standards and quality control protocols required for federal supply chains. Their technical expertise lies in the formulation, packaging, and distribution of finished dosage forms, particularly those used in clinical and long-term care settings. While specific product lines are not detailed, their work under the Federal Supply Schedule suggests a capability to deliver standardized, high-volume pharmaceuticals with consistent batch integrity and regulatory traceability. The contractor has established a direct relationship with the Department of Veterans Affairs, supplying pharmaceuticals through its Federal Supply Schedule program. This indicates a proven ability to meet VA’s stringent requirements for drug procurement, including formulary alignment, therapeutic equivalence, and just-in-time logistics for veteran care facilities. Their engagement with the VA underscores a niche positioning in supporting chronic disease management and hematologic therapies within the veteran population. ACCORD BIOPHARMA’s primary industry focus is NAICS 325412—Pharmaceutical Preparation Manufacturing—where they operate as a specialized producer of finished drug products rather than active pharmaceutical ingredients. This vertical specialization positions them as a contract manufacturer serving government health systems that require reliable, compliant, and scalable pharmaceutical supply. Their market role centers on bridging the gap between bulk drug synthesis and end-user delivery in federal healthcare environments. As a small business structured as a 2L entity based in Raleigh, North Carolina, ACCORD BIOPHARMA operates with a lean, focused model. The company holds no formal government certifications, but its successful award under the VA’s FSS program demonstrates its capacity to navigate federal procurement regulations and maintain quality systems aligned with FDA and GPO standards. Their geographic presence supports efficient distribution to eastern U.S. federal medical facilities.